Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.cochrane.org › pl › CD014962Remdesiwir w leczeniu chorych na COVID-19 - Cochrane

   www.cochrane.org › pl › CD014962

   • Zapisane w pamięci cache

   Nie ustalono dokładnie, czy remdesiwir zwiększa czy zmniejsza szansę na polepszenie stanu zdrowia pacjentów. Podczas stosowania remdesiwiru może wystąpić mniej poważnych działań niepożądanych niż w przypadku placebo lub standardowej opieki zdrowotnej.

   • English

     Hospitalised people with moderate to severe COVID-19....

   • Bahasa Malaysia

     Kami mencari kajian yang menyiasat remdesivir untuk merawat...

   • Deutsch

     In keiner Studie wurden Personen mit symptomloser...

   • Remdesivir

     中度至重度 covid-19 的住院患者. 瑞德西韋可能對 28 天、60 天後的死亡或 150...

2. www.thelancet.com › journals › lanresEffects of remdesivir in patients hospitalised with COVID-19: a...

   www.thelancet.com › journals › lanres

   21 lut 2023 · The evidence for the effect of remdesivir in patients hospitalised with COVID-19 who were receiving high-flow oxygen or more intensified respiratory support before receiving remdesivir is inconclusive, which could be related to the small sample size.

3. www.thelancet.com › journals › lancetWhen and which patients should receive remdesivir?

   www.thelancet.com › journals › lancet

   21 maj 2022 · Still, the research conducted by the WHO Solidarity Trial Consortium 5 adds meaningfully to the evidence base by demonstrating that we now know remdesivir can reduce the risk of death or progression of mechanical ventilation (or both) in hospitalised patients with COVID-19 requiring oxygen therapy. A great strength of Solidarity is the ...

4. zdrowie.wprost.pl › profilaktyka-i-leczenie › lekiRemdesivir w leczeniu COVID-19 skuteczniejszy z lekami na...

   zdrowie.wprost.pl › profilaktyka-i-leczenie › leki

   • Zapisane w pamięci cache

   30 kwi 2021 · Połączenie remdesiviru, leku zatwierdzonego do leczenia pacjentów z COVID-19, oraz leków zwykle stosowanych w wirusowym zapaleniu wątroby typu C (HCV), okazało się 10 razy skuteczniejsze od...

5. pubs.acs.org › doi › 10Remdesivir: A Review of Its Discovery and Development Leading to...

   pubs.acs.org › doi › 10

   Subsequent evaluation by numerous virology laboratories demonstrated the ability of remdesivir to inhibit coronavirus replication, including SARS-CoV-2. Here, we provide an overview of remdesivir’s discovery, mechanism of action, and the current studies exploring its clinical effectiveness.

6. pubmed.ncbi.nlm.nih.gov › 33433843Remdesivir and COVID-19 infection, therapeutic benefits or ... -...

   pubmed.ncbi.nlm.nih.gov › 33433843

   21 sty 2021 · Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks? Ir J Med Sci. 2021 Nov;190 (4):1637-1638. doi: 10.1007/s11845-020-02482-2. Epub 2021 Jan 12. Authors. Antonio Vitiello 1 , Francesco Ferrara 2 , Raffaele La Porta 3. Affiliations.

7. pubmed.ncbi.nlm.nih.gov › 34331674Efficacy and safety of remdesivir in hospitalised COVID-19 ... -...

   pubmed.ncbi.nlm.nih.gov › 34331674

   Despite conditional recommendation against its use, remdesivir could still be effective in early clinical improvement; reduction of early mortality and avoiding high-flow supplemental oxygen and invasive mechanical ventilation among hospitalised COVID-19 patients.